Insights
white paper
The Shift Toward US Pharmaceutical Manufacturing: Considerations in Attaining the Right Global Mix
The COVID-19 pandemic has brought the global interdependency of pharmaceutical supply chains into sharp focus, exposing weak links and re-igniting discussions around the value of reshoring production. The U.S. Food and Drug Administration (FDA) repor...
1